Mark Cobbold

Company: AstraZeneca

Job title: Senior Vice President, Cell Therapy & Immuno-oncology, Discovery, Oncology R&D

Seminars:

Strategies to Overcome Challenges with Development of Cell Therapy for Solid Tumors 10:00 am

Advancing innovative strategies to ‘armor’ cell therapies with the goal of enabling them to resist the immuno-suppressive TME We are advancing a portfolio of CAR-Ts and TCR-Ts that aim to unlock a range of important targets in cancer. Preclinical and early clinical data are showing the potential of our approach across hard-to-treat solid cancers Beyond…Read more

day: Post-Conference Solid Tumor Focus Day